세계의 신경 내시경 시장 보고서(2025년)
Neuroendoscopy Global Market Report 2025
상품코드 : 1760647
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신경 내시경 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.1%의 CAGR로 10억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 성장의 원동력은 로봇 공학의 활용 확대, 신경외과 연구개발에 대한 투자 확대, 개별화 및 표적화된 신경학적 치료에 대한 수요 증가, 내시경 검사에서 첨단 영상 기술의 채택 확대, 전 세계 신경외과 전문 센터의 확대 등이 될 것으로 보입니다. 예측 기간의 주요 동향으로는 고해상도 및 3D 신경 내시경 시스템의 개발, 신경 내시경에 인공지능의 고도화된 통합, 복잡한 시술에 대응하는 유연하고 초박형 내시경의 개발, 최소침습적 수술법의 혁신, 일회용 신경 내시경 기구의 개선 등이 있습니다.

뇌종양 발생률의 증가는 향후 몇 년 동안 신경 내시경 시장의 성장을 견인할 것으로 예상됩니다. 뇌종양은 뇌와 척추관 내의 비정상적인 세포 증식으로 악성 또는 양성일 수 있습니다. 이러한 종양은 뇌 기능에 영향을 미칠 수 있으며, 종류와 부위에 따라 외과적, 방사선학적, 내과적 치료가 필요한 경우가 많습니다. 뇌종양의 증가는 영상 진단의 향상과 이온화 방사선 및 산업 오염 물질과 같은 환경적 위험 요인에 대한 노출 증가와 관련이 있습니다. 신경 내시경은 뇌종양 치료를 위한 최소침습적 방법을 제공하여 외상 감소, 빠른 회복, 적은 합병증으로 종양을 제거하거나 생검할 수 있습니다. 예를 들어, 2023년 Cancer Australia가 보고한 뇌종양 신규 발병 건수는 약 1,924건으로, 호주 전체 신규 암 발병 건수의 1.2%를 차지합니다. 이처럼 뇌종양 사례의 증가는 신경 내시경 시장의 성장에 기여하고 있습니다.

신경 내시경 시장 업체들은 수술 정확도 향상, 침습성 감소, 빠른 회복, 치료 가능한 신경 질환의 범위 확대를 목표로 바이포털 내시경 수술 시스템 등의 혁신에 집중하고 있습니다. 바이포털 내시경 시스템은 관찰용과 수술용의 두 가지 진입점을 사용합니다. 이 접근 방식은 더 선명한 영상, 더 정확한 시술, 더 빠른 회복 시간을 제공합니다. 예를 들어, 미국 조이맥스(Joimax)는 2023년 10월 척추 수술용 iLESSYS 이중 내시경 시스템을 출시했습니다. 이 시스템은 삼각측량, 관류 제어, 조직 절제술을 위한 도구를 갖추고 있으며, 바이포털과 바이매뉴얼 시술을 모두 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계 시장 : 경쟁 벤치마킹·대시보드

제33장 주요 기업 인수합병(M&A)

제34장 최근의 시장 동향

제35장 시장 잠재력 높은 나라·부문과 전략

제36장 부록

ksm
영문 목차

영문목차

Neuroendoscopy is a minimally invasive surgical method used to diagnose and treat neurological conditions, including brain tumors, epilepsy, and cerebrovascular disorders. It involves using specialized endoscopic instruments inserted through small incisions, providing a less invasive option compared to traditional surgery. The main objective is to deliver precise treatment with minimal damage to surrounding tissues, which leads to faster recovery, reduced infection risks, and lower healthcare expenses. This technique enhances surgical accuracy, improves patient outcomes, and aligns with the growing trend toward minimally invasive approaches in neurosurgery.

The primary products in neuroendoscopy include rigid neuroendoscopes, rigid fiberscopes, rigid videoscopes, and flexible neuroendoscopes. Rigid neuroendoscopes are straight, inflexible instruments frequently used in brain surgeries. They provide high-resolution imaging via a lens system, allowing surgeons to clearly view internal brain structures. These instruments are used in procedures such as tumor removal and endoscopic third ventriculostomy (ETV) for both adult and pediatric patients. The procedures are typically carried out by various end users, such as hospitals, clinics, and clinical laboratories.

The neuroendoscopy market research report is one of a series of new reports from The Business Research Company that provides neuroendoscopy market statistics, including the neuroendoscopy industry global market size, regional shares, competitors with the neuroendoscopy market share, detailed neuroendoscopy market segments, market trends, and opportunities, and any further data you may need to thrive in the neuroendoscopy industry. This neuroendoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neuroendoscopy market size has grown strongly in recent years. It will grow from $0.73 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to factors such as the growing preference for quicker recovery procedures, increased use of neuroendoscopy in pediatric neurosurgeries, technological advancements in endoscopic tools, heightened awareness among both patients and surgeons about the benefits of neuroendoscopy, and rising healthcare spending, along with improvements in hospital infrastructure.

The neuroendoscopy market size is expected to see strong growth in the next few years. It will grow to $1.04 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period is expected to be driven by the increasing use of robotics in neuroendoscopy, growing investments in neurosurgical research and development, a higher demand for personalized and targeted neurological treatments, greater adoption of advanced imaging technologies in endoscopy, and the expansion of specialized neurosurgery centers globally. Key trends in the forecast period include developments in high-definition and 3D neuroendoscopic systems, the advanced integration of artificial intelligence in neuroendoscopy, the creation of flexible and ultra-thin endoscopes for complex procedures, innovations in minimally invasive surgical methods, and improvements in disposable neuroendoscopy instruments.

The increasing incidence of brain tumors is expected to drive the growth of the neuroendoscopy market in the coming years. Brain tumors are abnormal cell growths within the brain or spinal canal, which can either be malignant or benign. These tumors can impact brain function and often require surgical, radiological, or medical treatments, depending on their type and location. The rise in brain tumor cases is linked to better diagnostic imaging and increased exposure to environmental risk factors, including ionizing radiation and industrial pollutants. Neuroendoscopy provides a minimally invasive method for treating brain tumors, enabling tumor removal or biopsy with reduced trauma, quicker recovery, and fewer complications. For example, in 2023, Cancer Australia reported approximately 1,924 new cases of brain cancer, making up 1.2% of all new cancer cases in the country. Thus, the growing number of brain tumor cases is contributing to the growth of the neuroendoscopy market.

Companies in the neuroendoscopy market are focusing on innovations such as the biportal endoscopic surgical system to improve surgical precision, reduce invasiveness, speed up recovery, and extend the scope of treatable neurological conditions. A biportal endoscopic system uses two entry points one for viewing and one for operating. This approach offers clearer imaging, more accurate procedures, and faster recovery times. For instance, in October 2023, Joimax, a US-based company, launched the iLESSYS biportal endoscopic system for spinal surgery, which enhances precision and freedom of movement through biportal access. The system features tools for triangulation, irrigation control, and tissue resection, supporting both biportal and bimanual techniques.

In August 2024, KARL STORZ, a German medical technology company, acquired Asensus Surgical Inc. for an undisclosed sum. This acquisition enhances KARL STORZ's capabilities in robotic surgery, enabling the provision of AI-driven, minimally invasive solutions that improve surgical precision and patient outcomes. Asensus Surgical Inc., based in the US, specializes in digital surgical technologies.

Major players in the neuroendoscopy market are Medtronic plc, Stryker Corporation, Schindler Endoskopie Technologie GmbH, Carl Zeiss Meditec AG, Karl Storz SE & Co. KG, Integra LifeSciences Holdings Corporation, Natus Medical Incorporated, Aesculap AG, Richard Wolf GmbH, Brainlab AG, B. Braun Melsungen AG, Clarus Medical LLC, ATMOS MedizinTechnik GmbH & Co. KG, NeuroOne Medical Technologies Corporation, Machida Endoscope Co. Ltd., Adeor Medical AG, Cliniva Healthcare, Inova Technology GmbH, Zhejiang Tiansong Medical Instrument Co. Ltd., Tonglu WANHE Medical Instrument Co. Ltd.

North America was the largest region in the neuroendoscopy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroendoscopy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroendoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroendoscopy market consists of revenues earned by entities providing services such as minimally invasive neurosurgeries, diagnostic imaging, patient care, and post-operative recovery solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroendoscopy market also includes sales of advanced endoscopic equipment, surgical tools, diagnostic imaging systems, and specialized surgical instruments used in neurosurgery. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroendoscopy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroendoscopy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neuroendoscopy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroendoscopy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Neuroendoscopy Market Characteristics

3. Neuroendoscopy Market Trends And Strategies

4. Neuroendoscopy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neuroendoscopy Growth Analysis And Strategic Analysis Framework

6. Neuroendoscopy Market Segmentation

7. Neuroendoscopy Market Regional And Country Analysis

8. Asia-Pacific Neuroendoscopy Market

9. China Neuroendoscopy Market

10. India Neuroendoscopy Market

11. Japan Neuroendoscopy Market

12. Australia Neuroendoscopy Market

13. Indonesia Neuroendoscopy Market

14. South Korea Neuroendoscopy Market

15. Western Europe Neuroendoscopy Market

16. UK Neuroendoscopy Market

17. Germany Neuroendoscopy Market

18. France Neuroendoscopy Market

19. Italy Neuroendoscopy Market

20. Spain Neuroendoscopy Market

21. Eastern Europe Neuroendoscopy Market

22. Russia Neuroendoscopy Market

23. North America Neuroendoscopy Market

24. USA Neuroendoscopy Market

25. Canada Neuroendoscopy Market

26. South America Neuroendoscopy Market

27. Brazil Neuroendoscopy Market

28. Middle East Neuroendoscopy Market

29. Africa Neuroendoscopy Market

30. Neuroendoscopy Market Competitive Landscape And Company Profiles

31. Neuroendoscopy Market Other Major And Innovative Companies

32. Global Neuroendoscopy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroendoscopy Market

34. Recent Developments In The Neuroendoscopy Market

35. Neuroendoscopy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기